(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are PCI BIOTECH HOLD, SAS AB, and NEL.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| PCI BIOTECH HOLD (PCIB.OL) | 2.75 | 67.38% | 2024-05-28 12:42:06 |
| SAS AB (SASNO.OL) | 0.04 | 17.93% | 2024-05-28 12:42:47 |
| NEL (NEL.OL) | 8.53 | 15.15% | 2024-05-28 12:41:19 |
| ARAMIS GROUP (ARAMI.PA) | 4.59 | 10.74% | 2024-05-28 12:45:39 |
| ATLANTIC SAPPHIRE (ASA.OL) | 1.20 | 9.89% | 2024-05-28 12:24:39 |
| POLIGHT (PLT.OL) | 2.81 | 8.93% | 2024-05-28 12:42:21 |
| ULTIMOVACS (ULTI.OL) | 7.67 | 7.27% | 2024-05-28 12:44:05 |
| HEXAGON COMPOSITES (HEX.OL) | 26.90 | 7.17% | 2024-05-28 12:40:24 |
| MPC CONTAINER SHIP (MPCC.OL) | 21.51 | 6.75% | 2024-05-28 12:41:11 |
| NX FILTRATION (NXFIL.AS) | 5.27 | 6.53% | 2024-05-28 12:03:14 |
The three biggest losers today are VIVORYON, BIOSENIC, and AUGROS COSMETICS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| VIVORYON (VVY.AS) | 2.87 | -33.72% | 2024-05-28 12:04:36 |
| BIOSENIC (BIOS.BR) | 0.02 | -18.24% | 2024-05-28 12:05:23 |
| AUGROS COSMETICS (AUGR.PA) | 6.15 | -7.52% | 2024-05-28 12:46:00 |
| UNIFIEDPOST GROUP (UPG.BR) | 3.29 | -6.27% | 2024-05-28 12:21:50 |
| HØLAND OG SETSKOG (HSPG.OL) | 122.02 | -6.14% | 2024-05-28 12:40:32 |
| DISTRI-LAND CERT (DISL.BR) | 198.00 | -5.71% | 2024-05-28 12:05:56 |
| HOFSETH BIOCARE (HBC.OL) | 2.05 | -4.65% | 2024-05-28 12:40:26 |
| NEXT BIOMETRICS GP (NEXT.OL) | 7.66 | -4.01% | 2024-05-28 12:41:21 |
| INCLUSIO SA/NV (INCLU.BR) | 13.15 | -3.31% | 2024-05-28 12:20:20 |
| ASR NEDERLAND (ASRNL.AS) | 46.28 | -2.98% | 2024-05-28 12:00:38 |
Winners today
1. PCI BIOTECH HOLD (PCIB.OL)
67.38% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 67.38% to €2.75 on Tuesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.03% to €1,433.82, following the last session’s upward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.
Volume
Today’s last reported volume for PCI BIOTECH HOLD is 6336010 which is 7179.01% above its average volume of 87045.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCI BIOTECH HOLD’s stock is considered to be oversold (<=20).
Moving Average
PCI BIOTECH HOLD’s worth is way above its 50-day moving average of kr1.70 and way above its 200-day moving average of kr1.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 2.99M for the twelve trailing months.
More news about PCI BIOTECH HOLD.
2. SAS AB (SASNO.OL)
17.93% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 134 aircraft, including 16 long-haul aircraft, 87 short-haul aircraft, and 31 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB jumping 17.93% to €0.04 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.03% to €1,433.82.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-0.64.
Volatility
SAS AB’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.54%, a positive 2.71%, and a positive 7.81%.
SAS AB’s highest amplitude of average volatility was 22.14% (last week), 10.01% (last month), and 7.81% (last quarter).
More news about SAS AB.
3. NEL (NEL.OL)
15.15% Price Change
Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEL jumping 15.15% to €8.53 on Tuesday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.03% to €1,433.82, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, NEL has a trailing twelve months EPS of kr-0.41.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.
Volatility
NEL’s last week, last month’s, and last quarter’s current intraday variation average was 4.38%, 2.39%, and 3.45%.
NEL’s highest amplitude of average volatility was 4.62% (last week), 3.64% (last month), and 3.45% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 14%, now sitting on 1.73B for the twelve trailing months.
Volume
Today’s last reported volume for NEL is 23585100 which is 166.82% above its average volume of 8839020.
More news about NEL.
4. ARAMIS GROUP (ARAMI.PA)
10.74% Price Change
Aramis Group SAS engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Belgium, Austria, Italy, and Spain. It operates under the Aramisauto, Cardoen, Clicars, CarSupermarket, Onlinecars, and Brumbrum brands. The company was founded in 2001 and is based in Arcueil, France. Aramis Group SAS operates as a subsidiary of Stellantis Auto SAS.
CAC 40 ended the session with ARAMIS GROUP rising 10.74% to €4.59 on Tuesday while CAC 40 dropped 0.92% to €8,057.80.
Earnings Per Share
As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-0.4.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARAMIS GROUP’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for ARAMIS GROUP is 150899 which is 253.95% above its average volume of 42632.
More news about ARAMIS GROUP.
5. ATLANTIC SAPPHIRE (ASA.OL)
9.89% Price Change
Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.
Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE jumping 9.89% to €1.20 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.03% to €1,433.82.
Earnings Per Share
As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-3.93.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.
Volatility
ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was 0.94%, 1.38%, and 4.12%.
ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 1.70% (last week), 4.06% (last month), and 4.12% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.
Volume
Today’s last reported volume for ATLANTIC SAPPHIRE is 5201020 which is 7.97% below its average volume of 5651760.
More news about ATLANTIC SAPPHIRE.
6. POLIGHT (PLT.OL)
8.93% Price Change
poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLIGHT jumping 8.93% to €2.81 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.03% to €1,433.82.
Earnings Per Share
As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 22.51M for the twelve trailing months.
Yearly Top and Bottom Value
POLIGHT’s stock is valued at kr2.81 at 22:40 EST, way under its 52-week high of kr25.70 and way higher than its 52-week low of kr2.34.
Volatility
POLIGHT’s last week, last month’s, and last quarter’s current intraday variation average was 2.24%, 0.06%, and 5.51%.
POLIGHT’s highest amplitude of average volatility was 3.47% (last week), 3.31% (last month), and 5.51% (last quarter).
Moving Average
POLIGHT’s worth is way below its 50-day moving average of kr3.30 and way below its 200-day moving average of kr11.58.
More news about POLIGHT.
7. ULTIMOVACS (ULTI.OL)
7.27% Price Change
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS rising 7.27% to €7.67 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.03% to €1,433.82.
Earnings Per Share
As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.94%.
Moving Average
ULTIMOVACS’s value is way under its 50-day moving average of kr33.11 and way below its 200-day moving average of kr88.30.
More news about ULTIMOVACS.
8. HEXAGON COMPOSITES (HEX.OL)
7.17% Price Change
Hexagon Composites ASA, together with its subsidiaries, engages in the manufacture and sale of composite pressure cylinders and fuel systems for alternative fuels worldwide. The company operates through Hexagon Agility, Hexagon Ragasco, and Hexagon Digital Wave segments. The Hexagon Agility segment provides clean fuel solutions for commercial vehicles, passenger vehicles, and gaseous energy transportation; and gas distribution solutions. The Hexagon Ragasco segment manufacturers composite liquefied petroleum gas (LPG) cylinders for leisure, household, and industrial applications. The Hexagon Digital Wave segment offers cylinder testing and monitoring technology solutions that reduce cylinder and system down-time and inspection costs while improving inspection accuracy. Hexagon Composites ASA was founded in 1985 and is headquartered in Ålesund, Norway.
Oslo Børs Benchmark Index_GI ended the session with HEXAGON COMPOSITES jumping 7.17% to €26.90 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.03% to €1,433.82.
Earnings Per Share
As for profitability, HEXAGON COMPOSITES has a trailing twelve months EPS of kr-5.7.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.17%.
More news about HEXAGON COMPOSITES.
9. MPC CONTAINER SHIP (MPCC.OL)
6.75% Price Change
MPC Container Ships ASA owns and operates a portfolio of container vessels. The company focuses on small-to mid-size vessels that are chartered out on time-charter contracts to global and regional liner shipping companies serving intra-regional trade lanes. It operates a fleet of 59 vessels with an aggregate capacity of approximately 126,943 twenty-foot equivalent units. The company was incorporated in 2017 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with MPC CONTAINER SHIP rising 6.75% to €21.51 on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.03% to €1,433.82, following the last session’s upward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, MPC CONTAINER SHIP has a trailing twelve months EPS of kr8.2.
PE Ratio
MPC CONTAINER SHIP has a trailing twelve months price to earnings ratio of 2.62. Meaning, the purchaser of the share is investing kr2.62 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.09%.
Volatility
MPC CONTAINER SHIP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.83%, a positive 0.92%, and a positive 2.30%.
MPC CONTAINER SHIP’s highest amplitude of average volatility was 3.76% (last week), 2.38% (last month), and 2.30% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MPC CONTAINER SHIP’s stock is considered to be oversold (<=20).
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 19, 2024, the estimated forward annual dividend rate is 5.49 and the estimated forward annual dividend yield is 27.73%.
More news about MPC CONTAINER SHIP.
10. NX FILTRATION (NXFIL.AS)
6.53% Price Change
NX Filtration N.V. develops, manufactures, and sells hollow fiber membrane modules in Netherlands, Europe, North America, Asia, and internationally. The company offers direct nanofiltration, ultrafiltration, and microfiltration membrane modules that remove bacteria, viruses, micropollutants, color, and selective salts from water without pre-treatment and use of chemicals. It provides HYDRAcap ultrafiltration modules to treat surface water, ground water, sedawater, and wastewaters as pretreatment to reverse osmosis and nanofiltration; and Projection Tool, and intuitive and online platform that enables the rapid and iterative system design for dNF membranes. In addition, the company offers integrated rack design and testing and piloting services. The company was incorporated in 2016 and is headquartered in Enschede, the Netherlands.
AEX-Index ended the session with NX FILTRATION jumping 6.53% to €5.27 on Tuesday while AEX-Index fell 0.42% to €912.23.
Earnings Per Share
As for profitability, NX FILTRATION has a trailing twelve months EPS of €-0.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.78%.
Yearly Top and Bottom Value
NX FILTRATION’s stock is valued at €5.27 at 22:40 EST, way under its 52-week high of €11.00 and way higher than its 52-week low of €2.55.
Volatility
NX FILTRATION’s last week, last month’s, and last quarter’s current intraday variation average was 5.57%, 1.76%, and 3.62%.
NX FILTRATION’s highest amplitude of average volatility was 5.57% (last week), 3.12% (last month), and 3.62% (last quarter).
More news about NX FILTRATION.
Losers Today
1. VIVORYON (VVY.AS)
-33.72% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON dropping 33.72% to €2.87 on Tuesday while AEX-Index dropped 0.42% to €912.23.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.
Volatility
VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was 41.11%, 6.48%, and 7.71%.
VIVORYON’s highest amplitude of average volatility was 41.11% (last week), 10.53% (last month), and 7.71% (last quarter).
Volume
Today’s last reported volume for VIVORYON is 5910560 which is 394% above its average volume of 1196460.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VIVORYON’s stock is considered to be oversold (<=20).
More news about VIVORYON.
2. BIOSENIC (BIOS.BR)
-18.24% Price Change
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with BIOSENIC sliding 18.24% to €0.02 on Tuesday while BEL 20 slid 0.92% to €3,948.08.
Earnings Per Share
As for profitability, BIOSENIC has a trailing twelve months EPS of €7.3.
Volume
Today’s last reported volume for BIOSENIC is 14262300 which is 863.46% above its average volume of 1480320.
More news about BIOSENIC.
3. AUGROS COSMETICS (AUGR.PA)
-7.52% Price Change
Augros Cosmetic Packaging SA provides customized packaging solutions in France. The company offers decoration solutions for glass, plastic, and aluminum packaging materials. It serves the perfume, cosmetic, and spirit industries. The company is based in Alençon, France. Augros Cosmetic Packaging SA operates as a subsidiary of Famille Bourgine.
CAC 40 ended the session with AUGROS COSMETICS dropping 7.52% to €6.15 on Tuesday while CAC 40 fell 0.92% to €8,057.80.
Earnings Per Share
As for profitability, AUGROS COSMETICS has a trailing twelve months EPS of €0.43.
PE Ratio
AUGROS COSMETICS has a trailing twelve months price to earnings ratio of 14.3. Meaning, the purchaser of the share is investing €14.3 for every euro of annual earnings.
More news about AUGROS COSMETICS.
4. UNIFIEDPOST GROUP (UPG.BR)
-6.27% Price Change
UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.
BEL 20 ended the session with UNIFIEDPOST GROUP falling 6.27% to €3.29 on Tuesday, after four sequential sessions in a row of losses. BEL 20 fell 0.92% to €3,948.08, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-2.32.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71%.
Volume
Today’s last reported volume for UNIFIEDPOST GROUP is 20910 which is 58.78% above its average volume of 13169.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UNIFIEDPOST GROUP’s stock is considered to be overbought (>=80).
More news about UNIFIEDPOST GROUP.
5. HØLAND OG SETSKOG (HSPG.OL)
-6.14% Price Change
Høland og Setskog Sparebank provides banking services for the personal and corporate markets in Norway. It offers savings and pension accounts; consumer loans, business loans, mortgage loans, car loans, and loans for motorbikes, ATVs, motorhomes, caravans, snowmobiles, and boats; and refinancing, credit cards, mobile and online banking, bank guarantee, overdrafts, leasing, and factoring and invoice sales, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. Høland og Setskog Sparebank was founded in 1849 and is headquartered in Bjørkelangen, Norway.
Oslo Børs Benchmark Index_GI ended the session with HØLAND OG SETSKOG dropping 6.14% to €122.02 on Tuesday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.03% to €1,433.82, following the last session’s upward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr10.75.
PE Ratio
HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 11.35. Meaning, the purchaser of the share is investing kr11.35 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.83%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.4%, now sitting on 161.27M for the twelve trailing months.
Sales Growth
HØLAND OG SETSKOG’s sales growth is negative 17.5% for the present quarter and negative 7% for the next.
Volatility
HØLAND OG SETSKOG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.52%, a positive 0.70%, and a positive 2.16%.
HØLAND OG SETSKOG’s highest amplitude of average volatility was 1.52% (last week), 2.83% (last month), and 2.16% (last quarter).
Yearly Top and Bottom Value
HØLAND OG SETSKOG’s stock is valued at kr122.02 at 22:40 EST, way under its 52-week high of kr145.00 and above its 52-week low of kr120.00.
More news about HØLAND OG SETSKOG.
6. DISTRI-LAND CERT (DISL.BR)
-5.71% Price Change
Immobiliere Distri-Land NV engages in the issuing and managing of real estate certificates. The company was incorporated in 1989 and is based in Sint-Jans-Molenbeek, Belgium. Immobiliere Distri-Land NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with DISTRI-LAND CERT sliding 5.71% to €198.00 on Tuesday, after five successive sessions in a row of losses. BEL 20 fell 0.92% to €3,948.08, following the last session’s upward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, DISTRI-LAND CERT has a trailing twelve months EPS of €7.54.
PE Ratio
DISTRI-LAND CERT has a trailing twelve months price to earnings ratio of 26.26. Meaning, the purchaser of the share is investing €26.26 for every euro of annual earnings.
Volume
Today’s last reported volume for DISTRI-LAND CERT is 11 which is 1000% above its average volume of 1.
More news about DISTRI-LAND CERT.
7. HOFSETH BIOCARE (HBC.OL)
-4.65% Price Change
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.
Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE falling 4.65% to €2.05 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI fell 0.03% to €1,433.82, following the last session’s upward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.79%.
Moving Average
HOFSETH BIOCARE’s value is under its 50-day moving average of kr2.19 and way below its 200-day moving average of kr2.63.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HOFSETH BIOCARE’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
HOFSETH BIOCARE’s stock is valued at kr2.05 at 22:40 EST, way below its 52-week high of kr3.95 and above its 52-week low of kr1.90.
More news about HOFSETH BIOCARE.
8. NEXT BIOMETRICS GP (NEXT.OL)
-4.01% Price Change
NEXT Biometrics Group ASA, together with its subsidiaries, provides fingerprint sensor technology in Asia, Europe, Africa, and North America. The company offers fingerprint sensor modules and readers, flexible biometric subassemblies, and face recognition software, as well as software and hardware development kits. It also sells its products to office and notebooks; payment and fintech; access control; and public security sectors. The company sells its sensors to distributors and original equipment manufacturer of electronic components. NEXT Biometrics Group ASA was founded in 2000 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEXT BIOMETRICS GP dropping 4.01% to €7.66 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.03% to €1,433.82.
Earnings Per Share
As for profitability, NEXT BIOMETRICS GP has a trailing twelve months EPS of kr-0.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -78.69%.
Volume
Today’s last reported volume for NEXT BIOMETRICS GP is 75400 which is 41.06% below its average volume of 127947.
Yearly Top and Bottom Value
NEXT BIOMETRICS GP’s stock is valued at kr7.66 at 22:40 EST, way under its 52-week high of kr9.32 and way higher than its 52-week low of kr4.65.
Revenue Growth
Year-on-year quarterly revenue growth grew by 88.1%, now sitting on 40.38M for the twelve trailing months.
Moving Average
NEXT BIOMETRICS GP’s worth is way under its 50-day moving average of kr8.55 and above its 200-day moving average of kr7.09.
More news about NEXT BIOMETRICS GP.
9. INCLUSIO SA/NV (INCLU.BR)
-3.31% Price Change
Inclusio SA operates as a real estate company in Belgium. It focuses on affordable rental housing, housing for disabled, and social infrastructures. Inclusio SA was incorporated in 2011 and is based in Brussels, Belgium.
BEL 20 ended the session with INCLUSIO SA/NV falling 3.31% to €13.15 on Tuesday while BEL 20 slid 0.92% to €3,948.08.
Earnings Per Share
As for profitability, INCLUSIO SA/NV has a trailing twelve months EPS of €4.33.
PE Ratio
INCLUSIO SA/NV has a trailing twelve months price to earnings ratio of 3.04. Meaning, the purchaser of the share is investing €3.04 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.11%.
Volatility
INCLUSIO SA/NV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.45%, a positive 0.11%, and a positive 1.73%.
INCLUSIO SA/NV’s highest amplitude of average volatility was 1.45% (last week), 1.93% (last month), and 1.73% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.5%, now sitting on 13.83M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 22, 2024, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 5.28%.
More news about INCLUSIO SA/NV.
10. ASR NEDERLAND (ASRNL.AS)
-2.98% Price Change
ASR Nederland N.V. provides insurance, pensions, and mortgages products for consumers, self-employed persons, and companies. It operates through five segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. The company offers health, life, pension, funeral expense, and occupational disability insurance products; and non-life insurance products, including road traffic, fire, third-party liability and legal assistance insurance. It also provides financial intermediary services; and develops real estate properties, as well as operates as an asset manager for third parties. ASR Nederland N.V. offers its products under the Loyalis, Ditzo, Europeesche Verzekeringen, a.s.r. asset management, Ardanta, and a.s.r. brand names. The company was formerly known as Fortis Verzekeringen Nederland N.V. and changed its name to ASR Nederland N.V. in October 2008. ASR Nederland N.V. was founded in 1720 and is headquartered in Utrecht, the Netherlands.
AEX-Index ended the session with ASR NEDERLAND sliding 2.98% to €46.28 on Tuesday while AEX-Index fell 0.42% to €912.23.
Earnings Per Share
As for profitability, ASR NEDERLAND has a trailing twelve months EPS of €5.26.
PE Ratio
ASR NEDERLAND has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing €8.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.96%.
Yearly Top and Bottom Value
ASR NEDERLAND’s stock is valued at €46.28 at 22:40 EST, below its 52-week high of €49.16 and way above its 52-week low of €33.41.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASR NEDERLAND’s stock is considered to be overbought (>=80).
Moving Average
ASR NEDERLAND’s worth is higher than its 50-day moving average of €46.01 and way higher than its 200-day moving average of €41.82.
Volatility
ASR NEDERLAND’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.55%, a positive 0.15%, and a positive 0.79%.
ASR NEDERLAND’s highest amplitude of average volatility was 0.55% (last week), 0.73% (last month), and 0.79% (last quarter).
More news about ASR NEDERLAND.
Stay up to date with our winners and losers daily report
